Neuroprotection is the preservation of function and networks of neural tissues from damages
caused by various agents, as well as neurodegenerative diseases such as Parkinson's …

Brain photobiomodulation (PBM) therapy using red to near-infrared (NIR) light is an
innovative treatment for a wide range of neurological and psychological conditions. Red/NIR …

Photobiomodulation (PBM) describes the application of light at wavelengths ranging from
400–1100 nm to promote tissue healing, reduce inflammation and promote analgesia …

Photobiomodulation (PBM), also known as Low-level Laser Therapy (LLLT), involves the
use of light from a laser or light-emitting diode (LED) in the treatment of various disorders …

Alzheimer's and Parkinson's disease are the two most common neurodegenerative
disorders. They develop after a progressive death of many neurons in the brain. Although …

The global number of people with Alzheimer's disease (AD) doubles every 5 years. It has
been established that unless an effective treatment for AD is found, the incidence of AD will …

Beta amyloid (Aβ) is well accepted to play a central role in the pathogenesis of Alzheimer's
disease (AD). The present work evaluated the therapeutic effects of low-level laser …

Over the last seventy years or so, many previous studies have shown that
photobiomodulation, the use of red to near infrared light on body tissues, can improve …

Antimicrobial photodynamic therapy (APDT) is a promising approach to fight the growing
problem of antimicrobial resistance that threatens health care, food security and agriculture …

Molecularly generated light, referred to here as “molecular light”, mainly includes
bioluminescence, chemiluminescence, and Cerenkov luminescence. Molecular light …